Agenus, Inc. (AGEN)
7.67
-0.42
(-5.19%)
USD |
NASDAQ |
Aug 24, 16:00
7.67
0.00 (0.00%)
After-Hours: 20:00
Agenus Total Assets (Quarterly) : 172.69M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 172.69M |
| March 31, 2026 | 186.46M |
| December 31, 2025 | 226.80M |
| September 30, 2025 | 233.89M |
| June 30, 2025 | 185.22M |
| March 31, 2025 | 200.20M |
| December 31, 2024 | 226.27M |
| September 30, 2024 | 238.48M |
| June 30, 2024 | 292.42M |
| March 31, 2024 | 256.56M |
| December 31, 2023 | 313.91M |
| September 30, 2023 | 335.47M |
| June 30, 2023 | 383.59M |
| March 31, 2023 | 412.85M |
| December 31, 2022 | 413.56M |
| September 30, 2022 | 429.02M |
| June 30, 2022 | 456.17M |
| March 31, 2022 | 441.30M |
| December 31, 2021 | 465.96M |
| September 30, 2021 | 437.64M |
| June 30, 2021 | 192.30M |
| March 31, 2021 | 234.92M |
| December 31, 2020 | 214.51M |
| September 30, 2020 | 204.48M |
| June 30, 2020 | 185.78M |
| Date | Value |
|---|---|
| March 31, 2020 | 180.06M |
| December 31, 2019 | 155.34M |
| September 30, 2019 | 174.81M |
| June 30, 2019 | 206.71M |
| March 31, 2019 | 245.93M |
| December 31, 2018 | 136.40M |
| September 30, 2018 | 130.48M |
| June 30, 2018 | 131.94M |
| March 31, 2018 | 130.82M |
| December 31, 2017 | 138.40M |
| September 30, 2017 | 149.27M |
| June 30, 2017 | 176.49M |
| March 31, 2017 | 203.27M |
| December 31, 2016 | 156.99M |
| September 30, 2016 | 174.84M |
| June 30, 2016 | 196.45M |
| March 31, 2016 | 221.14M |
| December 31, 2015 | 242.23M |
| September 30, 2015 | 242.61M |
| June 30, 2015 | 180.11M |
| March 31, 2015 | 117.32M |
| December 31, 2014 | 74.53M |
| September 30, 2014 | 87.63M |
| June 30, 2014 | 100.19M |
| March 31, 2014 | 108.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 915.53M |
| Novavax, Inc. | 955.58M |
| Fate Therapeutics, Inc. | 260.10M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 378.54M |
| Shareholders Equity (Quarterly) | -199.08M |
| Debt to Equity Ratio | -1.458 |
| Current Ratio | 0.34 |
| Net Debt Paydown Yield | 19.44% |